上海盟科药业股份有限公司关于召开2025年第三次临时股东大会的通知

Core Points - The company Shanghai Mencor Pharmaceutical Co., Ltd. is convening its third extraordinary general meeting of shareholders in 2025 on November 7, 2025 [1] - The meeting will utilize the Shanghai Stock Exchange's online voting system for shareholders to cast their votes [2][4] - The meeting will include both on-site and online voting methods, with specific time slots designated for each [4][6] Meeting Details - The meeting will take place on November 7, 2025, at 14:00 at the designated location in Shanghai [4] - Shareholders must register to attend the meeting, with specific registration procedures outlined for different types of shareholders [10][11] - The company will publish relevant materials regarding the meeting on the Shanghai Stock Exchange's website prior to the event [5] Voting Procedures - Shareholders can vote through the online platform or in person, but duplicate votes will be disregarded, with the first vote counted [6][7] - Specific resolutions will be presented for voting, including special resolutions and those requiring separate counting for minority investors [6] - Certain related shareholders are required to abstain from voting on specific resolutions [6] Attendance Information - Only shareholders registered with the China Securities Depository and Clearing Corporation Limited as of the registration date are eligible to attend [8] - The company will not accept telephone registrations, and all registration must be completed by the specified deadline [11]